Toggle navigation
Home
Medical
Vitiligo From Checkpoint Inhibitors Not Limited to Melanoma
15-2-2022
Medical
https://www.medscape.com/cx/rssfeeds/2700.xml
82
Vitiligo can occur in any type of cancer, according to a new study published as a preprint and that has not yet peer reviewed. First Look
Share
Tweet
+1
Read The Rest
at : https://www.medscape.com/cx/rssfeeds/2700.xml
Related News
‘It’s Becoming Too Expensive to Live’: Older Adults Try...
Oral melanoma: a multicenter study of 69 patients from Japan
Kinase activity in renal cell carcinoma, benign renal...
PARP Inhibitors: Improving Outcomes in Metastatic...
Screening assays identify TMPRSS2 inhibitors from drug...
Minority Women Most Affected if Abortion is Banned, Limited
SGLT-2 Inhibitors, GLP1-RAs Show Cardiorenal Event...
How States Are Prioritizing Limited Vaccine Supplies
Vaccine May Keep Melanoma in Remission 4 Years
AstraZeneca warns of limited vaccine supplies to Europe